Ortec International (New York), a company focused on advancing regenerative medicine through the development of cellular technology and advanced biomaterial products, said the company's name has been changed to Forticell Bioscience.

In connection with the new name, the company's stock ticker symbol has been changed to “FORB.”

According to Ortec management, the new name was proposed because it more appropriately reflects the company's comprehensive product line, which has the leading commercial candidate of OrCel, a bilayered cellular matrix of engineered tissue to heal chronic and acute wounds, and two fibrin-derived advanced biomaterial technologies, Fibrin MicroBeads and Haptides, which were acquired in 2006.

No Comments